193 related articles for article (PubMed ID: 16597593)
1. A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis.
Takahashi T; Takahashi K; Mernaugh RL; Tsuboi N; Liu H; Daniel TO
Blood; 2006 Aug; 108(4):1234-42. PubMed ID: 16597593
[TBL] [Abstract][Full Text] [Related]
2. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
3. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins.
Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T
J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196
[TBL] [Abstract][Full Text] [Related]
4. Determination of the CD148-Interacting Region in Thrombospondin-1.
Takahashi K; Sumarriva K; Kim R; Jiang R; Brantley-Sieders DM; Chen J; Mernaugh RL; Takahashi T
PLoS One; 2016; 11(5):e0154916. PubMed ID: 27149518
[TBL] [Abstract][Full Text] [Related]
5. CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes.
de la Fuente-García MA; Nicolás JM; Freed JH; Palou E; Thomas AP; Vilella R; Vives J; Gayá A
Blood; 1998 Apr; 91(8):2800-9. PubMed ID: 9531590
[TBL] [Abstract][Full Text] [Related]
6. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development.
Takahashi T; Takahashi K; St John PL; Fleming PA; Tomemori T; Watanabe T; Abrahamson DR; Drake CJ; Shirasawa T; Daniel TO
Mol Cell Biol; 2003 Mar; 23(5):1817-31. PubMed ID: 12588999
[TBL] [Abstract][Full Text] [Related]
7. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
8. Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.
Takahashi K; Kim RH; Pasic L; He L; Nagasaka S; Katagiri D; May T; Shimizu A; Harris RC; Mernaugh RL; Takahashi T
Am J Physiol Renal Physiol; 2020 Mar; 318(3):F647-F659. PubMed ID: 31984788
[TBL] [Abstract][Full Text] [Related]
9. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
Jandt E; Denner K; Kovalenko M; Ostman A; Böhmer FD
Oncogene; 2003 Jul; 22(27):4175-85. PubMed ID: 12833140
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of receptor-type protein tyrosine phosphatase CD148 (HPTP eta/DEP-1) in Fc gamma receptor IIa signal transduction of human neutrophils.
Hundt M; Schmidt RE
Eur J Immunol; 1997 Dec; 27(12):3532-5. PubMed ID: 9464844
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1.
Palka HL; Park M; Tonks NK
J Biol Chem; 2003 Feb; 278(8):5728-35. PubMed ID: 12475979
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of human T cell activation by the receptor-type protein tyrosine phosphatase CD148.
Tangye SG; Wu J; Aversa G; de Vries JE; Lanier LL; Phillips JH
J Immunol; 1998 Oct; 161(8):3803-7. PubMed ID: 9780142
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
Lin YC; Liu CY; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase.
Tsuboi N; Utsunomiya T; Roberts RL; Ito H; Takahashi K; Noda M; Takahashi T
Biochem J; 2008 Jul; 413(1):193-200. PubMed ID: 18348712
[TBL] [Abstract][Full Text] [Related]
16. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
17. Expression on human eosinophils of CD148: a membrane tyrosine phosphatase. Implications in the effector function of eosinophils.
del Pozo V; Pirotto F; Cárdaba B; Cortegano I; Gallardo S; Rojo M; Arrieta I; Aceituno E; Palomino P; Gaya A; Lahoz C
J Leukoc Biol; 2000 Jul; 68(1):31-7. PubMed ID: 10914487
[TBL] [Abstract][Full Text] [Related]
18. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation.
Spring K; Chabot C; Langlois S; Lapointe L; Trinh NT; Caron C; Hebda JK; Gavard J; Elchebly M; Royal I
Blood; 2012 Sep; 120(13):2745-56. PubMed ID: 22898603
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PTPs by H(2)O(2) regulates the activation of distinct MAPK pathways.
Lee K; Esselman WJ
Free Radic Biol Med; 2002 Oct; 33(8):1121-32. PubMed ID: 12374624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
